Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...

Simple, Accurate, Affordable Solution for Pharmacogenomics Profiling to Identify Genetic Biomarkers Associated with Drug Response-- --Learn ...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ™, and several distinguished researchers will be ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology ...

Presentations at AMP 2025 show utility of Delve Detect for diagnosing complex CNS infections, such as co-infection and culture-negative presentations ...

OGT, using their specialised expertise in the development of superior hybridisation-based capture technology, ensures that ...

Biomarkers, AI & next-gen diagnostics offer new hope in India’s cancer battle: Nandita Vijayasimha, Bengaluru Friday, November 7, 2025, 09:00 Hrs [IST] Hospitals and pharma indu ...